Levels of miR-29b do not predict for response in patients with acute myelogenous leukemia treated with the combination of 5-azacytidine, valproic acid, and ATRA

Research output: Contribution to journalLetterpeer-review

21 Scopus citations

Fingerprint

Dive into the research topics of 'Levels of miR-29b do not predict for response in patients with acute myelogenous leukemia treated with the combination of 5-azacytidine, valproic acid, and ATRA'. Together they form a unique fingerprint.